Table 1.
General characteristics of the study population.
| Mean ± SD/median (IQR)/n (%) | |
|---|---|
| Population (n) | 133 |
| Age (years) | 55.64 ± 11.74 |
| Height (cm) | 160 ± 6.8 |
| Weight (kg) | 68 (58–78) |
| BSA (mq) | 1.7 (1.6–1.83) |
| BMI (kg/mq) | 26.4 (22.1–29.9) |
| Family history of CVD | 24 (18%) |
| Diabetes | 18 (13.5%) |
| Hypertension | 292 (1.8%) |
| Dyslipidemia | 29 (21.8%) |
| Smoking | 18 (13.5%) |
| ACE-I | 11 (8.27%) |
| Sartans | 8 (6%) |
| B-blockers | 11 (8.27%) |
| Diuretics | 9 (6.7%) |
BMI, body mass index; CVD, cardiovascular disease; ACE-I, angiotensin-converting enzyme inhibitors; B-blockers, beta-blockers.